Bringing the fundamentals into focus…
Back to Teva Pharmaceutical Industries Limited
How Teva Pharmaceutical Industries Limited stacks up
TEVA · against 58 other Healthcare companies of similar size
Growth
76/ 100
Near the top of its peers.
Ranked #9 of 59 · scores higher than 83% of peers
Bars: peers in each 10-point band of the growth score11 peers with a growth score of 70–79, including TEVA · Click a bar to see the companies
Why growth scores 76?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings per share growth, which is stronger than most Healthcare peers.
- Revenue growth is close to the peer norm. Revenue growth: 4.1% vs peer median 6.1%
- 3-year revenue growth is close to the peer norm. 3-year revenue growth: 4.9% vs peer median 5.8%
- Earnings per share turned from a loss to a profit. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = TEVA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | TEVA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 59 reported | 4.1% | 9.9% | 24% | 33% | |
| Earnings per share growthHigher is better · 47 reported | Not reported | 12.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 59 reported | 4.9% | 6.5% | 33% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around TEVA| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 56.7B USD | 96 | 79 | |
| 2 | 40.2B USD | 92 | 73 | |
| 3 | 4.61T JPY (≈$31.3B) | 89 | 76 | |
| 4 | 43.30T KRW (≈$31.2B) | 86 | 68 | |
| 4 | 56.0B USD | 86 | 39 | |
| 6 | 67.60T KRW (≈$48.7B) | 82 | 72 | |
| 7 | 31.3B USD | 78 | 63 | |
| 7 | 27.5B EUR (≈$30.2B) | 78 | 60 | |
| 9 | 534.1B HKD (≈$68.4B) | 76 | 75 | |
| 9 | 48.9B USD | 76 | 54 | |
| 9 | 52.7B EUR (≈$58.0B) | 76 | 71 | |
| 12 | 193.6B HKD (≈$24.8B) | 74 | 78 | |
| 13 | 63.0B USD | 73 | 65 | |
| 14 | 540.4B BRL (≈$97.3B) | 72 | 64 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score